APAC Vascular Graft Market

APAC Vascular Graft Market Size (2023 to 2028)

The APAC vascular graft market size is predicted to grow at a robust CAGR between 2023 to 2028. The Asia Pacific Vascular Graft Market is developing at a rapid pace.

The APAC vascular graft market is expected to be driven by the rising prevalence of diabetes, the high number of chronic kidney diseases, the increase in the incidence of end-stage renal disease, and necessitating hemodialysis across the region. Furthermore, the increased prevalence of thoracic and abdominal aortic aneurysms and peripheral aortic illness among the growing elderly population is expected to boost the market growth.

On the other hand, other factors such as high junk food intake, tobacco consumption, substance abuse, and alcohol addiction influence the vascular graft market. Abdominal Aortic Aneurysm (AAA) is a severe medical disorder in which the aorta swells and causes serious health problems. People over the age of 60 are at a higher risk. As a result, segment expansion growth is aided by the growing senior population and favorable reimbursement policies. 

In addition, with the emergence of minimally invasive surgeries that result in a shorter hospital stay and faster recovery, the demand for abdominal aortic aneurysm repair is expected to rise in the future. Furthermore, the increased burden of cardiovascular and renal ailments and sophisticated surgical techniques in hospitals will move the segment forward. Moreover, the rising patient pool and the launch of novel surgical methods will boost market revenue.

Infections linked to vascular grafts and a scarcity of competent doctors in developing nations could limit market expansion. The significant restriction is the high expense of therapy and complications associated with prosthetic grafts.

This research report on the APAC vascular graft market has been segmented and sub-segmented into the following categories:

By Product: 

• Peripheral Vascular Graft
• Endovascular Aneurysm Repair Stent Grafts
• Hemodialysis Access Graft

By Raw Material: 

• Biosynthetic
• Polyester
• Polyurethane (PU)
• Polytetrafluoroethylene (PTFE)

By End-User: 

• Ambulatory Surgical Centers
• Hospitals

By Application: 

• Coronary Artery Disease
• Aneurysm
• Vascular Occlusion
• Renal Failure
• Others

By Country:

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

The Asia Pacific is the fastest-growing region due to an increase in chronic diseases, growing medical tourism activities, and increased public and private healthcare expenditure. Emerging markets such as Singapore, China, Japan, and Australia create the considerable potential for competitors in the APAC vascular grafts market. Due to liberal regulatory rules and an increase in the burden of aneurysms, the market is likely to rise significantly in the following years.

The market for vascular grafts in China is expected to increase at 7.2% over the projected period, owing to improved healthcare infrastructure and rising rates of cardiovascular disorders (CVDs) and diabetes. Furthermore, because of the rapid epidemiological transformation that has resulted in many premature deaths, demand for minimally invasive grafting techniques is likely to increase. Moreover, the demand for vascular grafts has increased in the country due to the development of creative and revolutionary vascular bypass procedures.

According to the Asia Pacific Society of Nephrology survey, chronic kidney disease affects roughly 17% Indians. In India, approximately 40% of people with diabetes experience signs of end-stage renal disease. As a result of the rising prevalence of diabetes and the high number of chronic kidney diseases, the incidence of end-stage renal disease would rise, necessitating hemodialysis.

KEY MARKET PLAYERS:

Endologix Inc., LeMaitre Vascular, Inc., MAQUET Holding B.V.B. Braun Melsungen AG, & Co. KG, Medtronic plc, C. R. Bard, Inc., Cardinal Health Inc., Cook Medical Inc., Terumo Corporation, and W. L. Gore & Associates, Inc. are the key players in the Asia Pacific Vascular Graft Market.